Skip to main content

Immunology

      RT @DrPetryna: @RheumNow #acr20 abs0063 in silico, in vitro &clinical study: Amitriptyline, naloxone& thalidomid

      Olga Petryna DrPetryna

      4 years 11 months ago
      @RheumNow #acr20 abs0063 in silico, in vitro &clinical study: Amitriptyline, naloxone& thalidomide prevent NOS2, IL6, IL1B, MMP9 release, inhibits NLRP3 inflammasome pathway> decreased colchicine consumption in gout pts using above meds for other indications #acrbest #different https://t.co/cz3htmtBU0
      RT @bella_mehta: #ACR20 keynote Infectious disease Dr Eric Rubin @NEJM EIC answers questions about medications, immunity

      Bella Mehta bella_mehta

      4 years 11 months ago
      #ACR20 keynote Infectious disease Dr Eric Rubin @NEJM EIC answers questions about medications, immunity and vaccines in #COVID19. Many post covid inflammatory symptoms but not sure if its because of background autoimmunity. Need more data. More to come in a few months @RheumNow
      RT @ejdein1: Eric Rubin, MD, editor-in-chief @NEJM: "All of the vaccines are based on the same hypothesis". Scary though

      Eric Dein ejdein1

      4 years 11 months ago
      Eric Rubin, MD, editor-in-chief @NEJM: "All of the vaccines are based on the same hypothesis". Scary thought in relying in one solution #ACR20. @RheumNow
      RT @ejdein1: Lots of JAK safety studies in #ACR20. Abst#0237 pooled 5 RCTs on UPA. Good safety numbers and low VTE rates

      Eric Dein ejdein1

      4 years 11 months ago
      Lots of JAK safety studies in #ACR20. Abst#0237 pooled 5 RCTs on UPA. Good safety numbers and low VTE rates, but watch out for herpes zoster trend, elevated in UPA (30>15mg) compared to MTX and ADA. @RheumNow
      RT @MeralElRamahiMD: Determining safety of a vaccine requires NUMBERS (more subjects to detect rare, serious side effect

      Meral K. El Ramahi, MD MeralElRamahiMD

      4 years 11 months ago
      Determining safety of a vaccine requires NUMBERS (more subjects to detect rare, serious side effects) and TIME (longer trials to be able to detect more delayed side effects) per Dr. Eric Rubin’s (ID physician’s) keynote address at #ACR20 @RheumNow
      RT @MeralElRamahiMD: “When we will have a vaccine. The answer is not so simple. Safety [of vaccines] is an important c

      Meral K. El Ramahi, MD MeralElRamahiMD

      4 years 11 months ago
      “When we will have a vaccine. The answer is not so simple. Safety [of vaccines] is an important component of making a decision to move forward.”- Dr. Eric Rubin at #ACR20. We want a vaccine that is both SAFE and EFFECTIVE! @RheumNow
      RT @KDAO2011: Dr. L Calabrese excellent review of irAEs and a proposed personalized algorithm for mgmt of irAE #ACR20 @L

      k dao KDAO2011

      4 years 11 months ago
      Dr. L Calabrese excellent review of irAEs and a proposed personalized algorithm for mgmt of irAE #ACR20 @LCalabreseDO @rheumnow He believes there should be more studies combining TNFi or IL-6 with CPI https://t.co/GbvgXtNJnI
      RT @KDAO2011: Dr. Noha Abdel-wahab on timing for grade 3/4 irAE fastest with the skin after exposure to CPI #ACR20 @rheu

      k dao KDAO2011

      4 years 11 months ago
      Dr. Noha Abdel-wahab on timing for grade 3/4 irAE fastest with the skin after exposure to CPI #ACR20 @rheumnow https://t.co/sc5c6Zn3Uq
      RT @uptoTate: “Immunology is the cornerstone of medicine and we are the experts.” #ACR20 president, Dr. Ellen Graval

      Dr. Rachel Tate uptoTate

      4 years 11 months ago
      “Immunology is the cornerstone of medicine and we are the experts.” #ACR20 president, Dr. Ellen Gravallese @RheumNow
      RT @ejdein1: JAKs are no longer new, Winthrop et al presents 8.4 year BARI data in Abst#0202 at #ACR20. VTE risk stable

      Eric Dein ejdein1

      4 years 11 months ago
      JAKs are no longer new, Winthrop et al presents 8.4 year BARI data in Abst#0202 at #ACR20. VTE risk stable over time, again shows reason to vaccinate patients for zoster before starting. @RheumNow https://t.co/OSIvHl2f7Y
      RT @bella_mehta: How would you change csDMARDS and bDMARDS a few days before vaccination - if/when #COVID19 KILLED vacci

      Bella Mehta bella_mehta

      4 years 11 months ago

      How would you change csDMARDS and bDMARDS a few days before vaccination - if/when #COVID19 KILLED vaccine comes in (Assuming live vaccine would need strict medication management.) #ACR20 @RheumNow

      RT @Janetbirdope: Vaccinate your pts against pneumococcal- it works! 595 vaccinated pts with RA & SpA vs 2379 nonvac

      Janet Pope Janetbirdope

      4 years 11 months ago
      Vaccinate your pts against pneumococcal- it works! 595 vaccinated pts with RA & SpA vs 2379 nonvaccinated followed to 10 yrs showed 50% less pneumonia if vaccinated even though those pts had more infections prior. Limitation not RCT & not vaccine I use @RheumNow @CRASCRRheum https://t.co/SySEL19Gcn
      RT @DrMiniDey: Delighted to be reporting for @RheumNow at #ACR20!

      Here, I review the last year in #infection in #rheuma

      Mrinalini Dey DrMiniDey

      4 years 11 months ago
      Delighted to be reporting for @RheumNow at #ACR20! Here, I review the last year in #infection in #rheumaticdiseases (it’s been a busy one!) and highlight just a few of the abstracts on infections (incl #COVID19), #vaccination and #immunogenicity. Enjoy! https://t.co/x1pzyOICAF
      Global Rheumatology Alliance Panel

      Dr. Kathryn Dao interviews Dr. Jinoos Yazdany, Dr. Philip Robinson and Dr. Jean Liew with the Global Rheumatology Alliance.

      COVID, Artificial Intelligence and Metabolomics at ACR 2020: Dr. Arthur Kavanaugh

      Dr. Arthur Kavanaugh provides an overview of the ACR 2020 meeting, including his review of COVID, machine learning (AI) and metabolomics sessions. 

      ×